| abstract |
The present invention relates to certain 4-substituted 1H-pyrrolo[2,3-b]pyridine compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds are useful for the treatment or prevention of diseases or medical conditions mediated through certain mutated forms of ErbB receptors, in particular exon20 Her2 and EGFR mutations. |